Skip to main content
Maximilian Konig, MD, Internal Medicine, Baltimore, MD

MaximilianKonigMD

Internal Medicine • Baltimore, MD

Rheumatology

Assistant Professor of Medicine; Director, Cellular Therapy Program (Autoimmunity)

Join to view full profile

Dr. Konig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Konig's full profile

Already have an account?

  • Office

    1800 Orleans St
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Summary

  • Dr. Maximilian Konig is a board-certified internist and rheumatologist affiliated with Johns Hopkins Hospital in Baltimore, MD. He received his medical degree from Charité - Universitätsmedizin Berlin and completed his residency training in Internal Medicine at Massachusetts General Hospital, Harvard Medical School. Dr. Konig concluded fellowship training in Clinical and Molecular Rheumatology as well as Advanced Rheumatology at Johns Hopkins Hospital.

    • Konig Lab at Johns Hopkins

    Our lab at Johns Hopkins develops antigen-specific immunotherapies for the treatment of autoimmune rheumatic disease and cancer.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2020 - 2021
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2019 - 2021
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2018 - 2020
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2017 - 2018
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 2016 - 2017
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2012 - 2016
  • Humboldt University of Berlin - Charite Faculty of Medicine
    Humboldt University of Berlin - Charite Faculty of MedicineClass of 2012, MD

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2019 - 2026
  • MA State Medical License
    MA State Medical License 2016 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow, American College of Physicians 2022
  • Jerome L. Greene Foundation Scholar 2021
  • Distinguished Fellow Award American College of Rheumatology, 2021
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agents  
    Li S, Jun T, Wang Z, Kao YH, Schadt E, Konig MF, Bettegowda C, Vogelstein JT, Papadopoulos N, Parsons RE, Chen R, Schadt EE, Li L, Oh WK, medRxiv, 2021
  • The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19  
    Rose L, Graham LA, Koenecke A, Powell M, Xiong R, Shen Z, Kinzler KW, Bettegowda C, Vogelstein B, Konig MF, Athey S, Vogelstein JT, Wagner TH, medRxiv, 12/22/2020
  • Digit Ulcerations in a Young Woman  
    Maximilian Konig, MD, JAMA
  • Join now to see all

Authored Content

  • A 37-year-old woman with lupus and pneumoniaApril 2022
  • A 57-year-old woman with new-onset hypertensionFebruary 2022
  • A 74-year-old man with acute onset of fevers, headaches, and neck painDecember 2021
  • A 35-year-old woman with subjective fevers, weakness, and joint painNovember 2021
  • Join now to see all

Press Mentions

  • Rheumatologists Face Challenges in Identifying High-Quality COVID-19 Literature
    Rheumatologists Face Challenges in Identifying High-Quality COVID-19 LiteratureAugust 28th, 2020
  • Alpha Blockers to Ease Severe COVID-19 Symptoms by Preventing ‘Cytokine Storm’
    Alpha Blockers to Ease Severe COVID-19 Symptoms by Preventing ‘Cytokine Storm’May 28th, 2020
  • Anti Hypertensive Drug May Prevent Complications of COVID-19
    Anti Hypertensive Drug May Prevent Complications of COVID-19May 20th, 2020
  • Join now to see all

Committees

  • Member, American College of Rheumatology, Early Career Investigator Subcommittee 2022 - Present
  • Member, American College of Rheumatology, Abstract Oversight Subcommittee 2021 - Present
  • Member, American College of Rheumatology, ACR-Food and Drug Administration Summit Organizing Committee 2021 - 2021
  • Fellow-in-Training Member, American College of Rheumatology, Committee on Research 2020 - 2021
  • Member, COVID-19 Global Rheumatology Alliance, Clinical Advisory Sub-Committee 2020 - 2021
  • Fellow-in-Training Member, Rheumatology Research Foundation, Board of Directors
 2019 - 2020
  • Fellow-in-Training Member, American College of Rheumatology, Committee on Journal Publications
 2018 - 2019

Professional Memberships

Other Languages

  • German

External Links

  • Homepagehttps://www.hopkinsmedicine.org/profiles/details/maximilian-konig
  • Lab Websitehttp://www.koniglab.org

Dr. Maximilian Konig, Dr. Maximilian Konig, MD, Dr. M Konig